OBIO
Orchestra BioMed Holdings, Inc.
Nasdaq · CIK 1814114
Last close5.95
Daily change-0.40 (-6.30%)
10 Years gain-47.81%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
OBIO · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
42.6Momentum
0.0Acceleration
0.0Confidence
63.0Annual Revenue4
Quarterly Revenue14
Annual CFO5
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth17.3 / 25
Quality8.1 / 25
Capital Efficiency0.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Gross margin compression · MEDIUMGross margin compressed by 2.1803 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 2390.867 percentage points.
Heavy share dilution · HIGHDiluted share count increased 66.8927%.
Key Metrics
Revenue Growth TTM-41.75%OK
Revenue CAGR 3Y111.62%OK
Gross Margin91.98%OK
Operating Margin-4,436.52%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y66.89%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $33.48M | $33.29M | -$51.81M | -$48.96M | -$49.45M | 99.43% | -154.73% | -147.7% | n/a | 47.75M |
| 2025 FY Dec 31, 2024 | $2.64M | $2.43M | -$64.30M | -$50.56M | -$50.85M | 92.27% | -2,437.49% | -1,927.48% | n/a | 36.82M |
| 2024 FY Dec 31, 2023 | $2.76M | $2.57M | -$51.51M | -$46.13M | -$46.21M | 93.26% | -1,866.16% | -1,674.09% | n/a | 33.23M |
| 2023 FY Dec 31, 2022 | $3.53M | $3.32M | -$32.66M | -$29.29M | -$29.88M | 94.03% | -924.34% | -845.74% | n/a | 14.99M |
| 2022 FY Dec 31, 2021 | n/a | n/a | -$394,756.00 | -$272,362.00 | n/a | n/a | n/a | n/a | n/a | 20.45M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.90M | sum latest 4 fiscal quarters Revenue | OK | 0001104659-26-093357, 0001104659-25-109128 |
| Revenue Growth TTM | -41.75% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001104659-26-093357, 0001104659-25-109128 |
| Revenue CAGR 3Y | 111.62% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-026754 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001104659-26-026754 |
| Gross Profit CAGR 3Y | 115.6% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001104659-26-026754 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001104659-26-093357, 0001104659-25-109128 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 91.98% | Gross Profit / Revenue | OK | 0001104659-26-093357, 0001104659-25-109128 |
| Operating Margin | -4,436.52% | Operating Income / Revenue | OK | 0001104659-26-093357, 0001104659-25-109128 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001104659-26-093357 |
| Current Ratio | 8.26x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.03 | Revenue / Diluted Shares | OK | 0001104659-26-093357, 0001104659-25-109128 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001104659-26-026754 |